about
Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinomaStretta: a valuable endoscopic treatment modality for gastroesophageal reflux diseasePatterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugsCelecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I StudyColorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID useAntimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States.Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitorsGastrointestinal dysfunction following hemolytic uremic syndrome.Persistent constipation and abdominal adverse events with newer treatments for constipation.Barrett's esophagus: progression to adenocarcinoma and markers.Adverse effects of long-term proton pump inhibitor therapy.Cameron ulcers: you will find only what you seek.Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.Concurrent conditions in patients with chronic constipation: a population-based study.Endoscopic therapies for gastroesophageal reflux disease.Guide to the use of proton pump inhibitors in adult patients.What is left of the endoscopic antireflux devices?Screening for esophageal adenocarcinoma: an evidence-based approach.Clinical experience with the Stretta procedure.Stretta: an effective, minimally invasive treatment for gastroesophageal reflux disease.Belching: dyspepsia or gastroesophageal reflux disease?Exercise and gastrointestinal function and disease: an evidence-based review of risks and benefits.Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry.GERD: the potential for endoscopic intervention.Communicating with patients with inflammatory bowel disease.Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy.Endoscopic therapy for Barrett's esophagus.Endoscopic antireflux therapy: the Stretta procedure.Endoscopic appearance of esophageal hematomasInjection therapies for nonbleeding disorders of the GI tract.Interventional upper endoscopy: the adult perspective.The manuscript review process.Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's EsophagusEndotherapy and surgery for GERD.Injection therapies for nonvariceal bleeding disorders of the GI tract.The association between cholecystectomy and gastroesophageal reflux symptoms: a prospective controlled study.Injection therapies for variceal bleeding disorders of the GI tract.Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.Utility of wireless motility capsule and lactulose breath testing in the evaluation of patients with chronic functional bloating.
P50
Q24646856-E0D4B8A0-8DB6-4E94-83B9-37CC87151354Q27027594-5E4AAB9A-33AF-42D9-A701-D9A10AC3A3CDQ28193079-18BEDA6A-7869-442E-B47F-64E67EB88666Q28195282-0359472B-CB61-40B6-80A6-C650D9B4C56BQ28196063-FB2C77DC-0F53-4FCA-BCC7-F061C53E2781Q30427337-6039233A-D227-46CA-9A5A-61F0E55DB09FQ33289145-6E5F98B2-AC13-421B-B8CC-A640DFCFEB74Q33337244-34F28663-1CCA-46AB-B033-A43FDE66CF2BQ33395266-591CB8B4-927F-44C5-8D65-D9B924DAFDCBQ33468562-D5BBD17E-897B-43DC-94AA-F9E4FAEBF463Q34032319-B8579D4D-CC09-4624-84AB-F13F542F3119Q34167899-DBDC9644-B51D-4F6F-97BD-533F7B6D86F2Q34195518-43277BCD-A268-4819-B1EE-3A0382F1A335Q34331150-5556F007-2EDA-4313-99E0-7445CF3A1DE3Q34446731-5D85AE4D-6C73-4D7A-8626-AB3963C844D2Q34637383-AF96EAE8-73C2-45FD-AB34-64E9FD0DC80CQ34775943-D1108004-3A97-4123-B4A8-7608FA63BDD8Q34973938-3C695639-918B-45E1-978F-732393CA6DE6Q34994551-EB8C0717-982E-429A-BA47-34AEBCF639F8Q35149855-F85790F6-2F0F-42A5-909E-060B53840BBEQ35203140-6D5BDA43-8B3E-4265-A65D-1702E36A3E58Q35565628-D96AAEFD-B412-4A9C-9F67-A0CFC410BCB8Q35689629-9F5209AE-4F05-43F7-8367-8BDF758E3C89Q35863931-0B09758F-EB2C-4452-99DA-B16E6F4A7AC0Q35895348-DAD7AE6E-2EF0-4337-9637-B3582582DAC2Q35913924-E39646FC-0F75-4FE8-BB4B-A511D9691D4FQ36023728-921F08B1-4BAD-4453-8090-0E9C89FF979EQ36179993-B512CE63-02D4-47CF-950C-F00629801322Q36231906-17FA0BC3-6DCE-44BE-B6F0-EDFFE2D55A5BQ36491951-F3D6117A-577A-40E3-A2EF-DE080B2B3635Q36572953-2758D2F5-8F65-4293-82F4-D1E67A94522EQ36653894-5005FF50-533C-4066-BDBA-1D04192A9C6FQ36657257-EC4349B5-4CC1-483F-A14A-6B0BFC1A0CEDQ36672337-CD36B8F8-B871-45D8-A061-226D6516CC0DQ36851921-BBF76F50-1460-4372-990D-7C09F94490DFQ36887905-5BDFC035-292A-4DD6-BC93-F5E75F506846Q36912242-36C62AF6-5C11-4E7E-A32D-030B1999F5CDQ37069681-A4669AAE-84BC-4C02-B171-36CB5DDD7565Q37114959-4B3EAF7D-6DEC-452E-9A03-C4F31EAD8057Q37236392-5EE21ED6-0909-4C11-9EF5-A566C16D9DE4
P50
name
George Triadafilopoulos
@ast
George Triadafilopoulos
@en
George Triadafilopoulos
@es
George Triadafilopoulos
@fr
George Triadafilopoulos
@nl
type
label
George Triadafilopoulos
@ast
George Triadafilopoulos
@en
George Triadafilopoulos
@es
George Triadafilopoulos
@fr
George Triadafilopoulos
@nl
prefLabel
George Triadafilopoulos
@ast
George Triadafilopoulos
@en
George Triadafilopoulos
@es
George Triadafilopoulos
@fr
George Triadafilopoulos
@nl